Predisone has quality-of-life benefits over flutamide in the treatment of hormone-resistant prostate cancer
-
Published:2001-06
Issue:2
Volume:2
Page:103-104
-
ISSN:1363-4054
-
Container-title:Evidence-based Oncology
-
language:en
-
Short-container-title:Evidence-based Oncology